These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1812344)

  • 1. From the relaxivity of Gd(DTPA)2- to everything else.
    Koenig SH
    Magn Reson Med; 1991 Dec; 22(2):183-90. PubMed ID: 1812344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
    Koenig SH
    Acta Radiol Suppl; 1990; 374():17-23. PubMed ID: 1966965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
    Tilcock C; Unger E; Cullis P; MacDougall P
    Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors determining the proton T1 relaxivity in solutions containing Gd-DTPA.
    Aime S; Nano R
    Invest Radiol; 1988 Sep; 23 Suppl 1():S264-6. PubMed ID: 3198359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
    Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K
    Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent.
    Adzamli K; Periasamy MP; Spiller M; Koenig SH
    Invest Radiol; 1999 Jun; 34(6):410-4. PubMed ID: 10353033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability of liposomal membranes to water: results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions.
    Koenig SH; Ahkong QF; Brown RD; Lafleur M; Spiller M; Unger E; Tilcock C
    Magn Reson Med; 1992 Feb; 23(2):275-86. PubMed ID: 1549042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
    Unger E; Needleman P; Cullis P; Tilcock C
    Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T.
    Reichenbach JR; Hackländer T; Harth T; Hofer M; Rassek M; Mödder U
    Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy.
    Devoisselle JM; Vion-Dury J; Galons JP; Confort-Gouny S; Coustaut D; Canioni P; Cozzone PJ
    Invest Radiol; 1988 Oct; 23(10):719-24. PubMed ID: 3192394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of polyaza macrocyclic methylene phosphonate chelates of Gd3+ ions as MRI contrast agents.
    Geraldes CF; Brown RD; Cacheris WP; Koenig SH; Sherry AD; Spiller M
    Magn Reson Med; 1989 Jan; 9(1):94-104. PubMed ID: 2540397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
    Vander Elst L; Van Haverbeke Y; Goudemant JF; Muller RN
    Magn Reson Med; 1994 Apr; 31(4):437-44. PubMed ID: 8208120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and clearance of liposomal gadolinium-DTPA.
    Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
    Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, physico-chemical characterization, and relaxometry studies of various gadolinium(III)-DTPA-bis(amide) derivatives as potential magnetic resonance contrast agents.
    Geraldes CF; Urbano AM; Alpoim MC; Sherry AD; Kuan KT; Rajagopalan R; Maton F; Muller RN
    Magn Reson Imaging; 1995; 13(3):401-20. PubMed ID: 7791550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early experience of paramagnetic tracers in ultra low magnetic fields.
    Paajanen H
    Acta Radiol Suppl; 1990; 374():81-3. PubMed ID: 1966974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvate structures in water-methanol solutions of MRI contrast agents: electron spin echo envelope modulation in gadolinium chelates.
    Clarkson RB; Hwang JH; Belford RL
    Magn Reson Med; 1993 Apr; 29(4):521-7. PubMed ID: 8385260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.